- Home
- MNPR vs HLXB Comparison
MNPR vs HLXB Comparison
Compare MNPR & HLXB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- HLXB
- Stock Information
- Founded
- MNPR 2014
- HLXB 2021
- Country
- MNPR United States
- HLXB United States
- Employees
- MNPR N/A
- HLXB N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- HLXB
- Sector
- MNPR Health Care
- HLXB
- Exchange
- MNPR Nasdaq
- HLXB NYSE
- Market Cap
- MNPR 244.1M
- HLXB 253.2M
- IPO Year
- MNPR 2019
- HLXB 2024
- Fundamental
- Price
- MNPR $39.59
- HLXB $10.77
- Analyst Decision
- MNPR Strong Buy
- HLXB
- Analyst Count
- MNPR 5
- HLXB 0
- Target Price
- MNPR $59.50
- HLXB N/A
- AVG Volume (30 Days)
- MNPR 27.1K
- HLXB 25.7K
- Earning Date
- MNPR 05-08-2025
- HLXB 01-01-0001
- Dividend Yield
- MNPR N/A
- HLXB N/A
- EPS Growth
- MNPR N/A
- HLXB N/A
- EPS
- MNPR N/A
- HLXB 0.36
- Revenue
- MNPR N/A
- HLXB N/A
- Revenue This Year
- MNPR N/A
- HLXB N/A
- Revenue Next Year
- MNPR N/A
- HLXB N/A
- P/E Ratio
- MNPR N/A
- HLXB $30.10
- Revenue Growth
- MNPR N/A
- HLXB N/A
- 52 Week Low
- MNPR $1.72
- HLXB $10.14
- 52 Week High
- MNPR $54.30
- HLXB $11.59
- Technical
- Relative Strength Index (RSI)
- MNPR 57.10
- HLXB N/A
- Support Level
- MNPR $26.06
- HLXB N/A
- Resistance Level
- MNPR $40.90
- HLXB N/A
- Average True Range (ATR)
- MNPR 4.78
- HLXB 0.00
- MACD
- MNPR 0.64
- HLXB 0.00
- Stochastic Oscillator
- MNPR 84.89
- HLXB 0.00
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About HLXB HELIX ACQUISITION CORP. II
Helix Acquisition Corp II is a Blank check company.